Insights into the Diverse Roles of miR-205 in Human Cancers

被引:40
|
作者
Orang, Ayla Valinezhad [1 ]
Safaralizadeh, Reza [1 ]
Feizi, Mohammad Ali Hosseinpour [1 ]
机构
[1] Univ Tabriz, Dept Anim Biol, Fac Nat Sci, Tabriz, Iran
关键词
miRNA; miR-205; biomarker; oncogene; tumor suppressor; EMT; SQUAMOUS-CELL CARCINOMA; EPITHELIAL-MESENCHYMAL TRANSITION; MICRORNA EXPRESSION PROFILES; LUNG-CANCER; MAMMALIAN MICRORNAS; DOWN-REGULATION; HUMAN PROSTATE; HEAD; ADENOCARCINOMA; NECK;
D O I
10.7314/APJCP.2014.15.2.577
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The recent discovery of tiny microRNAs (miRNAs) has brought about awareness of a new class of regulators of diverse pathways in many physiological and pathological processes, such as tumorigenesis. They modulate gene expression by targeting plethora of mRNAs, mostly reducing the protein yield of a targeted mRNA. With accumulation of information on characteristics of miR-205, complex and in some cases converse roles of miR-205 in tumor initiation, progression and metastasis are emerging. miR-205 acts either as an oncogene via facilitating tumor initiation and proliferation, or in some cases as a tumor suppressor through inhibiting proliferation and invasion. The aim of this review is to discuss miR-205 roles in different types of cancers. Given the critical effects of deregulated miR-205 on processes involved in tumorigenesis, they hold potential as novel therapeutic targets and biomarkers.
引用
收藏
页码:577 / 583
页数:7
相关论文
共 50 条
  • [1] The Important Roles of miR-205 in Normal Physiology, Cancers and as a Potential Therapeutic Target
    Vosgha, Haleh
    Salajegheh, Ali
    Smith, Robert Anthony
    Lam, Alfred King-Yin
    CURRENT CANCER DRUG TARGETS, 2014, 14 (07) : 621 - 637
  • [2] MiR-205 in cancer: An angel or a devil?
    Qin, Ai-Ying
    Zhang, Xin-Wei
    Liu, Liang
    Yu, Jin-Pu
    Li, Hui
    Wang, Shi-Zhen Emily
    Ren, Xiu-Bao
    Cao, Shui
    EUROPEAN JOURNAL OF CELL BIOLOGY, 2013, 92 (02) : 54 - 60
  • [3] MiR-205 as a promising biomarker in the diagnosis and prognosis of lung cancer
    Li, Jing-Hua
    Sun, Shan-Shan
    Li, Ning
    Lv, Peng
    Xie, Shu-Yang
    Wang, Ping-Yu
    ONCOTARGET, 2017, 8 (54) : 91938 - 91949
  • [4] miR-205: A Potential Biomedicine for Cancer Therapy
    Chauhan, Neeraj
    Dhasmana, Anupam
    Jaggi, Meena
    Chauhan, Subhash C.
    Yallapu, Murali M.
    CELLS, 2020, 9 (09)
  • [5] Targeting miR-205 in breast cancer
    Wu, Hailong
    Mo, Yin-Yuan
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2009, 13 (12) : 1439 - 1448
  • [6] Prognostic Significance of miR-205 in Endometrial Cancer
    Karaayvaz, Mihriban
    Zhang, Cecilia
    Liang, Sharon
    Shroyer, Kenneth R.
    Ju, Jingfang
    PLOS ONE, 2012, 7 (04):
  • [7] The expression and clinical significance of serum miR-205 for breast cancer and its role in detection of human cancers
    Zhang, Hui
    Li, Baowei
    Zhao, Hebao
    Chang, Jin
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (02): : 3034 - 3043
  • [8] MiR-205 determines the radioresistance of human nasopharyngeal carcinoma by directly targeting PTEN
    Qu, Changju
    Liang, Zhihui
    Huang, JiaLing
    Zhao, Ruiying
    Su, Chunhui
    Wang, Sumei
    Wang, Xudan
    Zhang, Rong
    Lee, Mong-Hong
    Yang, Huiling
    CELL CYCLE, 2012, 11 (04) : 785 - 796
  • [9] Low let-7d and high miR-205 expression levels positively influence HNSCC patient outcome
    Kolenda, Tomasz
    Guglas, Kacper
    Teresiak, Anna
    Blizniak, Renata
    Lamperska, Katarzyna
    JOURNAL OF BIOMEDICAL SCIENCE, 2019, 26 (1)
  • [10] Emerging roles of MiR-133a in human cancers
    Hua, Yu-Ting
    Xu, Wen-Xiu
    Li, Hui
    Xia, Min
    JOURNAL OF CANCER, 2021, 12 (01): : 198 - 206